Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?
Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7
Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease
Ana Urruticoechea-Arana; Jesús Sanz; Daniel Ginard; Yago González-Lama; Xavier Juanola; Miriam Almirall; Natalia Borruel; Jordi Gratacós; Estíbaliz Loza;
Reumatol Clin. 2023;19:423-9
Association of Anti-Saccharomyces cerevisiae antibodies with clinical phenotype in spondyloarthritis patients
Raquel Miriam Ferreira; Sofia Pimenta; Miguel Bernardes; Lúcia Costa;
Reumatol Clin. 2021;17:376-9